| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion due to NICE appraisal HST 13: Volanesorsen for treating familial chylomicronaemia syndrome |
|
Medicine details |
|
| Medicine name | volanesorsen (Waylivra®) |
| Formulation | solution for injection |
| Reference number | 3085 |
| Indication | As an adjunct to diet in adult patients with genetically confirmed familial chylomicronaemia syndrome (FCS) and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate |
| Company | Akcea Therapeutics UK Ltd |
| BNF chapter | Cardiovascular system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 05/07/2019 |
| NICE guidance | HST 13: Volanesorsen for treating familial chylomicronaemia syndrome |
| Commercial arrangement | PAS |